Exzell Pharma
Exzell Pharma is a Canadian specialty pharmaceutical and natural health products company, subsidiary of Biolab Farmacêutica Group, that markets OTC, vitamin and supplement brands (Swiss Natural, Ozonol, Myoflex, Salinex, PediaVit, EsopH) to Canadian consumers and, since 2023, pet supplements to veterinarians and pet owners.
- Company typePrivate
- Founded2014
- HeadquartersMarkham, Canada
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Exzell Pharma does
Exzell Pharma Inc. is a Canadian specialty pharmaceutical and natural health products company headquartered in Richmond Hill, Ontario, founded in 2014 and operating as a subsidiary of Brazilian pharmaceutical conglomerate Biolab Farmacêutica Group since 2022. The company markets a portfolio of OTC, natural health and consumer health brands serving Canadian consumers and, since 2023, Canadian pet owners and veterinary clinics. Core human-health brands include Swiss Natural® (vitamins, minerals and supplements, 50+ years on market), Ozonol® (topical first-aid ointment, 80+ years on market), Myoflex® (topical muscle and joint pain relief), Salinex® (nasal saline spray), PediaVit™ (pediatric vitamins and iron), and EsopH® (a patented oral GERD therapy combining chondroitin sulfate and hyaluronic acid). The animal health division, launched in 2023, sells the OGRAX family of Omega-3 and condition-specific supplements (OGRAX-3, OGRAX DERM, OGRAX ARTHRO/JOINT, OGRAX CELL, SENIOX T+) to veterinary clinics and pet owners.
Exzell generates revenue through multi-channel distribution: direct-to-consumer via the exzellshop.com e-commerce storefront, third-party retail pharmacy chains across Canada for OTC and natural health products, and a dedicated veterinary sales force that has onboarded 500+ Canadian vet clinics within one year of the Animal Health Division launch. Pricing is list-published at the consumer level and via contact with sales representatives; no enterprise-contract or SaaS-style pricing model is in use. A secondary revenue stream comes from licensing and distribution partnerships for third parties seeking to enter the Canadian OTC, NHP or prescription market, supported by Biolab's custom manufacturing and packaging capabilities across three manufacturing plants and three RDI centers in Brazil and Canada. The company does not operate its own AI/technology platform; product differentiation rests on heritage brand equity, patented formulations (EsopH), and regulatory expertise rather than software.
Exzell Pharma firmographics
Firmographics- Name
- Exzell Pharma
- Legal name
- Exzell Pharma Inc.
- Website
- https://exzell.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Exzell Pharma is a Canadian specialty pharmaceutical and natural health products company, subsidiary of Biolab Farmacêutica Group, that markets OTC, vitamin and supplement brands (Swiss Natural, Ozonol, Myoflex, Salinex, PediaVit, EsopH) to Canadian consumers and, since 2023, pet supplements to veterinarians and pet owners.
- Ownership category
- akta.pro rank
Exzell Pharma industry classification
Industry- Product category
- Consumer Pharmaceuticals & Natural Health Products
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Food (Health) Supplement Retailers (456191), Pet and Pet Supplies Retailers (45991)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Vitamins, Minerals & Multivitamin Supplements (HLAMALAF)
- akta.pro secondary industries
- Immune Support Supplements (HLAMALAE), Skin & Coat Supplements (HLAMALAB), Performance, Energy & Recovery Supplements (Active/Working Pets) (HLAMALAM)
Keywords
Where Exzell Pharma is headquartered
LocationHeadquarters
- HQ city
- Markham
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Exzell Pharma business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
Revenue model
- Pharmaceutical and Natural Health Product Sales: Exzell Pharma generates revenue through the sale of OTC pharmaceuticals, natural health products, and prescription alternatives across human and animal health divisions. Products are sold via direct e-commerce (exzellshop.com), retail pharmacies, and veterinary clinic channels. Revenue is derived from both one-time consumer purchases and recurring repurchases of branded consumer health products.
- Licensing and Distribution Partnerships: Exzell Pharma offers licensing and distribution solutions for innovative products entering the Canadian market, providing regulatory expertise, established market presence, and strategic partnerships for efficient market entry. Biolab Farmacêutica Group supports custom manufacturing and packaging for natural health products, cosmetics, and prescription categories.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
Exzell Pharma product offering
Product offeringCore offering
Exzell Pharma produces and supplies a portfolio of over-the-counter pharmaceuticals, natural health products, and specialty supplements in Canada for both human and animal health. Its human health line spans topical pain relief (Myoflex), first-aid ointments (Ozonol), nasal sprays (Salinex), vitamins and supplements (Swiss Natural, PediaVit), and a patented GERD therapy (EsopH). Its animal health division markets the OGRAX line of omega-3 and condition-specific nutritional supplements for dogs and cats via veterinary clinics.
Product overview
Exzell Pharma is a specialized pharmaceutical company offering a diverse portfolio of human health and animal health products rather than a unified technology platform. Their human health portfolio includes trusted heritage brands like Swiss Natural (vitamins/supplements, 50+ years), Ozonol (first-aid ointments, 80+ years), Myoflex (topical pain relief), Salinex (nasal sprays), and PediaVit (pediatric vitamins), alongside innovative products like EsopH (GERD treatment). In 2023, they expanded into animal health with the OGRAX line of omega-3 and specialized supplements (OGRAX-3, OGRAX DERM, OGRAX JOINT, OGRAX CELL, SENIOX T+) for dogs and cats. The company operates through an e-commerce platform (exzellshop.com) to distribute these products directly to consumers and veterinary clinics.
Differentiator
Problem solved
Functional benefit
Brands
- Swiss Natural®: Leading brand in vitamins, minerals, and supplements trusted for over 50 years, promoting good health at every life stage.
- Ozonol®
- Myoflex®
- Salinex®
- PediaVit™
- EsopH®
- OGRAX Family
- Exzell Animal Health
Products and services
- Swiss Natural A leading Canadian brand of vitamins, minerals, and supplements trusted for over 50 years, offering clinically proven solutions to promote health at every life stage for Canadian consumers.
- Ozonol A trusted Canadian household brand for over 80 years offering topical ointments for everyday first-aid, including relief for minor wounds, burns, skin irritations, insect bites, chafing, and chapping, available in antibiotic and non-antibiotic formulations.
- Myoflex A fast-acting, non-greasy, odourless topical cream for muscle and joint pain relief, available in multiple strengths and trusted by athletes and active individuals for sore muscles, sprains, strains, and arthritis pain.
- Salinex One of Canada's first nasal spray brands providing effective relief for nasal congestion, dryness, and irritation, with formulations designed to cleanse, moisturize, and soothe sensitive noses.
- PediaVit High-quality vitamin and iron supplements specifically designed for newborns and toddlers to meet essential nutritional needs at each stage of growth and development.
- EsopH A clinically proven oral therapy for managing GERD symptoms combining chondroitin sulfate to protect the esophageal lining with hyaluronic acid for tissue repair, forming a protective barrier against stomach acid.
- Exzell Human Health Division Core business division focused since 2014 on improving Canadian health through pharmaceutical and natural health products addressing diverse patient needs at every stage of life.
- Exzell Animal Health Division Division launched in 2023 dedicated to providing high-quality, science-backed pet care solutions for dogs and cats, offering advanced therapeutic solutions supporting pet health and well-being at every stage of life.
- OGRAX-3 Essential fatty acid (Omega-3) supplement sourced from cold-water marine fish, providing EPA and DHA in soft gel capsules for dogs and cats of all ages to support immune function, heart health, kidney health, eye health, and normal lipid metabolism.
- OGRAX CATS Omega-3 fatty acid supplement formulated specifically for cats to support overall feline health including immune function, heart health, and coat condition.
- OGRAX DERM Skin health supplement for pets that maintains normal epidermal barrier function and promotes healthy skin.
- OGRAX JOINT (OGRAX ARTHRO) Joint health supplement supporting normal mobility and joint health in pets.
- OGRAX CELL Ultra-concentrated DHA (docosahexaenoic acid) supplement for optimal physical performance, vitality, and good health in pets.
- SENIOX T+ Cognitive health supplement designed to support brain function in senior dogs.
- Swiss Natural Menolibrium A natural hormone-free solution for menopause symptoms containing the clinically proven EstroG-100 ingredient, sold under the Swiss Natural brand in the Canadian market.
- Swiss Natural Activated Charcoal A Swiss Natural-branded activated charcoal product formulated to relieve gas and bloating, expanding the digestive care portfolio.
Quantifiable outcome
- Over 500 veterinary clinics adopted Exzell Animal Health products within one year of launch
- +2 more outcomes
Companies that use Exzell Pharma
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Exzell Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Exzell Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Biolab Farmacêutica GroupcoreExzell Pharma became a subsidiary of Biolab Farmacêutica Group in 2022, a pivotal moment enhancing its ability to deliver innovative healthcare solutions. Biolab provides research and development capabilities through its Mississauga, Ontario RDI center, manufacturing support from three plants in Brazil (São Paulo and Minas Gerais), and international market access spanning Canada, Brazil, Europe and beyond. Biolab Group comprises over 4,000 professionals, 50+ international partnerships, and more than 400 patent applications.
Scale indicators7 records
Recent moves8 records
Expansion highlights6 records
Exzell Pharma competitors and assessment
Company assessmentDirect peers
- Jamieson Wellness: Canadian market leader in vitamins, minerals and supplements, including a strong heritage brand portfolio and direct-to-consumer channels. Closely comparable to Exzell on the Swiss Natural and PediaVit lines and on D2C distribution in Canada.
- Nutramax Laboratories: US-headquartered leader in pet joint, skin, and omega-3 supplements (Cosequin, Dasuquin). Highly comparable to Exzell's OGRAX line on product categories, formulation positioning, and veterinarian-channel distribution.
- Vetoquinol: Pure-play global veterinary pharmaceutical and specialty nutrition company. Closely comparable to Exzell Animal Health on veterinary-channel focus and companion animal supplement/pharma portfolio.
- Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals and nutrition company with strong international presence. Comparable to Exzell Animal Health on vet-only distribution and companion-animal health focus.
Broad incumbents
- Apotex: Largest Canadian generic pharmaceutical manufacturer with a broad portfolio and global reach. Comparable to Exzell as a Canadian pharma platform, though at much larger scale and with a generic-drug focus.
- Haleon: Global consumer health spin-off from GSK, with leading OTC brands across analgesics, nasal, oral health and vitamins. Comparable to Exzell's OTC franchise (Myoflex, Salinex) in category positioning and retail distribution.
- Nestlé Health Science: Global consumer health company spanning vitamins, supplements, and medical nutrition. Comparable to Exzell's supplement and pet nutrition portfolio and to its ambitions for international scale.
- Church & Dwight: Diversified US consumer health company with leading OTC and personal-care brands. Comparable to Exzell on heritage brand stewardship and grocery/retail mass distribution.
- Boehringer Ingelheim Animal Health: Global veterinary pharma and animal health division of Boehringer Ingelheim. Comparable to Exzell Animal Health on pet health portfolio and channel reach to veterinarians.
- Bayer Consumer Health: Global OTC and dietary supplement division of Bayer, with well-established brands across analgesics, vitamins and digestive health. Comparable to Exzell on the OTC portfolio (Myoflex, EsopH, Ozonol) and international commercial reach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Exzell Pharma social profiles
Digital presenceExzell Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Exzell Pharma leadership team
Management profileNumber of profiles
Exzell Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Exzell Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Exzell Pharma
What does Exzell Pharma do?
Exzell Pharma produces and supplies a portfolio of over-the-counter pharmaceuticals, natural health products, and specialty supplements in Canada for both human and animal health. Its human health line spans topical pain relief (Myoflex), first-aid ointments (Ozonol), nasal sprays (Salinex), vitamins and supplements (Swiss Natural, PediaVit), and a patented GERD therapy (EsopH). Its animal health division markets the OGRAX line of omega-3 and condition-specific nutritional supplements for dogs and cats via veterinary clinics.
Is Exzell Pharma a public or private company?
Exzell Pharma is a private company. It is classified as corporate owned and is currently operating.
When was Exzell Pharma founded?
Exzell Pharma was founded in 2014. It employs 11 to 50 people.
Where is Exzell Pharma based?
Exzell Pharma is headquartered in Markham, Canada, in the North America region.
How does Exzell Pharma make money?
Two revenue lines are on record. Pharmaceutical and Natural Health Product Sales are the primary driver. The others are licensing and Distribution Partnerships.
Who are Exzell Pharma's main competitors?
Direct peers on record are Jamieson Wellness, Nutramax Laboratories, Vetoquinol and Dechra Pharmaceuticals. Broad incumbents are Apotex, Haleon, Nestlé Health Science, Church & Dwight, Boehringer Ingelheim Animal Health and Bayer Consumer Health.
Does Exzell Pharma have an API?
No public API is recorded for Exzell Pharma.
What industry is Exzell Pharma in?
Exzell Pharma's product category is Consumer Pharmaceuticals & Natural Health Products. Its primary akta.pro industry code is HLAMALAF, Vitamins, Minerals & Multivitamin Supplements, with a secondary code of HLAMALAE, Immune Support Supplements. Its NAICS code is 325412 and its SIC code is 2834.